Literature DB >> 31122959

False-positive troponin I elevation in a newborn with neonatal encephalopathy.

Elisabetta Caredda1, Roberto Rosso2, Carlo Capristo1, Paolo Montaldo1,3.   

Abstract

Serum biomarkers of myocardial damage are commonly used in babies after perinatal asphyxia. We present a case report of a persistently troponin I elevation without evidence of clinical or instrumental signs of myocardial ischaemia in a baby with perinatal asphyxia. When the blood was mixed with polyethylene glycol we found that the troponin I levels were falsely elevated due to interfering antibodies. This case shows that analytical errors may still occur despite modern immunoassay systems and underlines the need for further investigations to identify false-positive values in case of disagreement between clinical conditions and laboratory values. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  ischaemic heart disease; neonatal intensive care; neurological injury

Mesh:

Substances:

Year:  2019        PMID: 31122959      PMCID: PMC6536162          DOI: 10.1136/bcr-2019-229217

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  Macro thyrotropin-IgG complex causes factitious increases in thyroid-stimulating hormone screening tests in a neonate and mother.

Authors:  David J Halsall; Michael N Fahie-Wilson; S Kate Hall; Peter Barker; Janet Anderson; Rousseau Gama; V Krishna Chatterjee
Journal:  Clin Chem       Date:  2006-10       Impact factor: 8.327

Review 2.  Heterophilic antibody interference in immunometric assays.

Authors:  Nils Bolstad; David J Warren; Kjell Nustad
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2013-06-20       Impact factor: 4.690

3.  Multiple admissions to the coronary care unit due to falsely elevated cardiac troponin.

Authors:  Mohamed Ayan; Zaid Gheith; Aneesha Ananthula; Mohsin Salih; Srikanth Vallurupalli; Jawahar L Mehta
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-03-15

4.  Matrix and bilirubin interference for high-sensitivity cardiac troponin I.

Authors:  Janet Simons; Lori Beach; Lorna Clark; Peter A Kavsak
Journal:  Clin Chim Acta       Date:  2015-01-18       Impact factor: 3.786

Review 5.  Analytically false or true positive elevations of high sensitivity cardiac troponin: a systematic approach.

Authors:  Mehrshad Vafaie; Moritz Biener; Matthias Mueller; Philipp A Schnabel; Florian André; Henning Steen; Markus Zorn; Melanie Schueler; Stefan Blankenberg; Hugo A Katus; Evangelos Giannitsis
Journal:  Heart       Date:  2013-04-25       Impact factor: 5.994

6.  Elevated thyroid-stimulating hormone level in a euthyroid neonate caused by macro thyrotropin-IgG complex.

Authors:  Mariane Rix; Peter Laurberg; Christina Porzig; Søren Risom Kristensen
Journal:  Acta Paediatr       Date:  2011-03-07       Impact factor: 2.299

Review 7.  Cardiovascular dysfunction in infants with neonatal encephalopathy.

Authors:  Katey Armstrong; Orla Franklin; Deirdre Sweetman; Eleanor J Molloy
Journal:  Arch Dis Child       Date:  2011-07-27       Impact factor: 3.791

8.  Falsely elevated cardiac troponin I levels.

Authors:  Amgad N Makaryus; Mary N Makaryus; Babak Hassid
Journal:  Clin Cardiol       Date:  2007-02       Impact factor: 2.882

Review 9.  Therapeutic Hypothermia: How Can We Optimize This Therapy to Further Improve Outcomes?

Authors:  Girija Natarajan; Abbot Laptook; Seetha Shankaran
Journal:  Clin Perinatol       Date:  2018-02-23       Impact factor: 3.430

10.  Serum sample containing endogenous antibodies interfering with multiple hormone immunoassays. Laboratory strategies to detect interference.

Authors:  Elena García-González; Maite Aramendía; Diego Álvarez-Ballano; Pablo Trincado; Luis Rello
Journal:  Pract Lab Med       Date:  2015-11-27
View more
  1 in total

1.  Characterization of canine anti-mouse antibodies highlights that multiple strategies are needed to combat immunoassay interference.

Authors:  Daniel Bergman; Anders Larsson; Helene Hansson-Hamlin; Emma Åhlén; Bodil Ström Holst
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.